Results 181 to 185 of about 9,435 (185)

Heterologous prime-boost vaccine regimens against Chlamydia trachomatis

2014
Chlamydia trachomatis is the most common bacterial sexually transmitted disease in man and despite decades of effort, there is still no protective vaccine. Left untreated, genital infection can lead to pelvic inflammatory disease, ectopic pregnancy, and infertility. However, infection-induced immunity in both animal models and humans indicates a strong
openaire   +2 more sources

Heterologous prime-boost: breaking the protective immune response bottleneck of COVID-19 vaccine candidates

Emerging Microbes and Infections, 2021
Cui Bopei, Miao Xu, Zhenglun Liang
exaly  

Heterologous Prime Boost Vaccine

2022
WOLLMANN GUIDO, DAS KRISHNA, DEROUAZI MADIHA, BELNOUE ELODIE, ELBERS KNUT   +4 more
openaire   +2 more sources

Heterologous Prime-Boost Immunization with DNA Vaccine and Modified Recombinant Proteins Enhances Immune Response against Trueperella pyogenes in Mice

Vaccines, 2022
Bisong Yue, Kelei Zhao, Ting Huang
exaly  

Efficacy of Heterologous Prime-Boost Vaccination with H3N2 Influenza Viruses in Pre-Immune Individuals: Studies in the Pig Model

Viruses, 2020
Kristien Van Reeth, Koen Chiers, Elien Vandoorn   +2 more
exaly